Testing the treatment effect on competing causes of death in oncology clinical trials

od Rotolo, Federico, Michiels, Stefan
Izdano 2014

Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials

od Ternès, Nils, Rotolo, Federico, Michiels, Stefan
izdano v BMC Med Res Methodol (2017)

Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials

od Ternès, Nils, Rotolo, Federico, Heinze, Georg, Michiels, Stefan
izdano v Trials (2015)

Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces

od Ternès, Nils, Rotolo, Federico, Heinze, Georg, Michiels, Stefan
izdano v Biom J (2016)

An alternative trial-level measure for evaluating failure-time surrogate endpoints based on prediction error

od Belhechmi, Shaima, Michiels, Stefan, Paoletti, Xavier, Rotolo, Federico
izdano v Contemp Clin Trials Commun (2019)

Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models

od Belhechmi, Shaima, Bin, Riccardo De, Rotolo, Federico, Michiels, Stefan
izdano v BMC Bioinformatics (2020)

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis

od Lueza, Béranger, Rotolo, Federico, Bonastre, Julia, Pignon, Jean-Pierre, Michiels, Stefan
izdano v BMC Med Res Methodol (2016)

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis

od Lueza, Béranger, Rotolo, Federico, Bonastre, Julia, Pignon, Jean-Pierre, Michiels, Stefan
izdano v BMC Med Res Methodol (2016)

Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology

od Texier, Matthieu, Rotolo, Federico, Ducreux, Michel, Bouché, Olivier, Pignon, Jean-Pierre, Michiels, Stefan
izdano v Comput Math Methods Med (2018)

Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer

od Rotolo, Federico, Zhu, Chang-Qi, Brambilla, Elisabeth, Graziano, Stephen L., Olaussen, Ken, Le-Chevalier, Thierry, Pignon, Jean-Pierre, Kratzke, Robert, Soria, Jean-Charles, Shepherd, Frances A., Seymour, Lesley, Michiels, Stefan, Tsao, Ming-Sound
izdano v Transl Lung Cancer Res (2018)

Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial

od Kreitman, Robert J., Dearden, Claire, Zinzani, Pier Luigi, Delgado, Julio, Robak, Tadeusz, le Coutre, Philipp D., Gjertsen, Bjørn T., Troussard, Xavier, Roboz, Gail J., Karlin, Lionel, Gladstone, Douglas E., Kuptsova-Clarkson, Nataliya, Liu, Shiyao, Patel, Priti, Rotolo, Federico, Mitry, Emmanuel, Pastan, Ira, Giles, Francis
izdano v J Hematol Oncol (2021)

Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer

od Devarakonda, Siddhartha, Rotolo, Federico, Tsao, Ming-Sound, Lanc, Irena, Brambilla, Elisabeth, Masood, Ashiq, Olaussen, Ken A., Fulton, Robert, Sakashita, Shingo, McLeer-Florin, Anne, Ding, Keyue, Le Teuff, Gwénaël, Shepherd, Frances A., Pignon, Jean-Pierre, Graziano, Stephen L., Kratzke, Robert, Soria, Jean-Charles, Seymour, Lesley, Govindan, Ramaswamy, Michiels, Stefan
izdano v J Clin Oncol (2018)

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis

od Rotolo, Federico, Pignon, Jean-Pierre, Bourhis, Jean, Marguet, Sophie, Leclercq, Julie, Tong Ng, Wai, Ma, Jun, Chan, Anthony T. C., Huang, Pei-Yu, Zhu, Guopei, Chua, Daniel T. T., Chen, Yong, Mai, Hai-Qiang, Kwong, Dora L. W., Soong, Yoke Lim, Moon, James, Tung, Yuk, Chi, Kwan-Hwa, Fountzilas, George, Zhang, Li, Hui, Edwin Pun, Lee, Anne W. M., Blanchard, Pierre, Michiels, Stefan
izdano v J Natl Cancer Inst (2016)